High materiality7/10
Oppenheimer Reiterates Outperform Rating on Ionis Pharmaceuticals (IONS)
Why it may matterVerify against the original reporting
bullish
Public signal · 1-minute delayed
Signal brief
Source-backed market context you can read and share without an account.
AI summary
What happened, with direct paths to the underlying reporting
Oppenheimer reiterates an Outperform rating with a target of $85; current price is $43.93.
- Outperform target $85; price $43.93
Key facts
- 01
Target: $85
- 02
Posted price: $43.93
- 03
Analyst firm: Oppenheimer
- 04
Analyst: Jay Olson
How to read this signal
Transparent limits for an AI-generated research aid
StockNews.AI groups source reporting, classifies the event, and measures subsequent price movement. This is informational research, not investment advice. Prices may be delayed or unavailable.